Stay updated on Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedFooter revision text updated to v3.3.2 and v3.2.0 removed; this is a minor site-version change and does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoval of a government funding operating status notice from the page, which previously informed users about potential delays and NIH/OPM operations; the page no longer displays that operating-status banner — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedThe new screenshot shows version updates including recruitment status and changes to contacts/locations, whereas the old screenshot did not reflect those latest updates. These version-level changes indicate ongoing updates to the trial record.SummaryDifference0.1%

- Check62 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference9%

- Check69 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.2%

- Check84 days agoChange DetectedRevision updated to v3.0.2; 'Back to Top' link removed.SummaryDifference0.5%

Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.